Apremilast-d5

Names

[ Name ]:
Apremilast-d5

[Synonym ]:
Apremilast D5
Apremilast-d5

Biological Activity

[Description]:

Apremilast D5 (CC-10004 D5) is a deuterium labeled Apremilast. Apremilast is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM. Apremilast inhibits TNF-α release by lipopolysaccharide (LPS) with an IC50 of 104 nM[1].

[Related Catalog]:

Signaling Pathways >> Apoptosis >> Apoptosis

Signaling Pathways >> Metabolic Enzyme/Protease >> Phosphodiesterase (PDE)

Research Areas >> Inflammation/Immunology

[Target]

PDE4

TNF-α

[References]

[1]. Perez-Aso M, et al. Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors. Arthritis Res Ther. 2015 Sep 15;17:249.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₂H₁₉D₅N₂O₇S

[ Molecular Weight ]:
465.53100

[ Exact Mass ]:
465.16200

[ PSA ]:
127.46000

[ LogP ]:
3.52590

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.